FDA Approves Biobeat's Blood Pressure Monitoring Devices
FDA Approves Biobeat's Blood Pressure Monitoring Devices
The U.S. Food and Drug Administration (FDA) has granted a 501K clearance for Biobeat patch and watch for measuring blood pressure
CES 2022: Consumers Now Can Buy 24-Hour Blood Pressure Kit
Disrupting Remote Patient Monitoring
Wearable Blood Pressure Monitors Global Market Growth Drivers, Share Report2032
7 Eye-Catching Wearables at MWC19
BioBeat's Cuffless Blood Pressure Monitoring Device, USA - Medical Device Network
A 24-Hour Skin Patch That Monitors Blood Pressure: The BioBeat Review
Biobeat receives FDA clearance for remote stroke volume and cardiac output monitoring devices - Cardiac Rhythm News
Biobeat - First and Only Company with FDA-Cleared Cuffless RPM to Screen Up to 13 Health Metrics
Biobeat Medical - smart vital signs monitoring
Nanowear gets FDA clearance for undergarment that estimates blood pressure
Blood Pressure Monitor, Quick FDA Approved For Health
FDA Clears the Biobeat Remote Patient Monitoring Device and Platform for Additional Vital Signs
Thai Heart - FDA approved Biobeat's “smartwatch and patch to monitor blood pressure and other vital signs.” The Israel-based company said this is the first FDA approval of a blood pressure monitor
Wearable technologies
Biobeat widens lead over Apple, Fitbit with FDA nod to add more vital sign monitoring to smartwatch
